<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30409217</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>The monocyte-macrophage-mast cell axis in dengue pathogenesis.</ArticleTitle><Pagination><StartPage>77</StartPage><MedlinePgn>77</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">77</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-018-0482-9</ELocationID><Abstract><AbstractText>Dengue virus, the causative agent of dengue disease which may have hemorrhagic complications, poses a global health threat. Among the numerous target cells for dengue virus in humans are monocytes, macrophages and mast cells which are important regulators of vascular integrity and which undergo dramatic cellular responses after infection by dengue virus. The strategic locations of these three cell types, inside blood vessels (monocytes) or outside blood vessels (macrophages and mast cells) allow them to respond to dengue virus infection with the production of both intracellular and secretory factors which affect virus replication, vascular permeability and/or leukocyte extravasation. Moreover, the expression of Fc receptors on the surface of monocytes, macrophages and mast cells makes them important target cells for antibody-enhanced dengue virus infection which is a major risk factor for severe dengue disease, involving hemorrhage. Collectively, these features of monocytes, macrophages and mast cells contribute to both beneficial and harmful responses of importance to understanding and controlling dengue infection and disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Shu-Wen</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu-Hsieh</LastName><ForeName>Betty A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wen-Yu</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Dalhousie University, Halifax, NS, B3H 4R2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3561-7604</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. robert.anderson@dal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Dalhousie University, Halifax, NS, B3H 4R2, Canada. robert.anderson@dal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Center for Vaccinology, Dalhousie University, Halifax, Canada. robert.anderson@dal.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dengue pathogenesis</Keyword><Keyword MajorTopicYN="N">Macrophage</Keyword><Keyword MajorTopicYN="N">Mast cell</Keyword><Keyword MajorTopicYN="N">Monocyte</Keyword><Keyword MajorTopicYN="N">Vascular leakage</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: not applicable. CONSENT FOR PUBLICATION: not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30409217</ArticleId><ArticleId IdType="pmc">PMC6225659</ArticleId><ArticleId IdType="doi">10.1186/s12929-018-0482-9</ArticleId><ArticleId IdType="pii">10.1186/s12929-018-0482-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest. 2004;113:946&#x2013;951. doi: 10.1172/JCI21512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI21512</ArticleId><ArticleId IdType="pmc">PMC379334</ArticleId><ArticleId IdType="pubmed">15057297</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengue. Lancet. 2007;370:1644&#x2013;1652. doi: 10.1016/S0140-6736(07)61687-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61687-0</ArticleId><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Harris E. Dengue. Lancet. 2015;385:453&#x2013;465. doi: 10.1016/S0140-6736(14)60572-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60572-9</ArticleId><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy B, Lang J, Saville M, Jackson N. Vaccination against dengue: challenges and current developments. Annu Rev Med. 2016;67:387&#x2013;404. doi: 10.1146/annurev-med-091014-090848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-091014-090848</ArticleId><ArticleId IdType="pubmed">26515983</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannice KS, Durbin A, Hombach J. Status of vaccine research and development of vaccines for dengue. Vaccine. 2016;34:2934&#x2013;2938. doi: 10.1016/j.vaccine.2015.12.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.12.073</ArticleId><ArticleId IdType="pubmed">26973072</ArticleId></ArticleIdList></Reference><Reference><Citation>Elong Ngono A, Shresta S. Immune response to dengue and zika. Annu Rev Immunol. 2018;36:279&#x2013;308. doi: 10.1146/annurev-immunol-042617-053142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053142</ArticleId><ArticleId IdType="pmc">PMC5910217</ArticleId><ArticleId IdType="pubmed">29345964</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige GN, Ogg GS. Pathogenesis of vascular leak in dengue virus infection. Immunology. 2017;151:261&#x2013;269. doi: 10.1111/imm.12748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12748</ArticleId><ArticleId IdType="pmc">PMC5461104</ArticleId><ArticleId IdType="pubmed">28437586</ArticleId></ArticleIdList></Reference><Reference><Citation>Voehringer D. Protective and pathological roles of mast cells and basophils. Nat Rev Immunol. 2013;13:362&#x2013;375. doi: 10.1038/nri3427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3427</ArticleId><ArticleId IdType="pubmed">23558889</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlin JS, Hallgren J. Mast cell progenitors: origin, development and migration to tissues. Mol Immunol. 2015;63:9&#x2013;17. doi: 10.1016/j.molimm.2014.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2014.01.018</ArticleId><ArticleId IdType="pubmed">24598075</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146:201&#x2013;217. doi: 10.1084/jem.146.1.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.146.1.201</ArticleId><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Wang SY. Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol. 2002;76:9877&#x2013;9887. doi: 10.1128/JVI.76.19.9877-9887.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.19.9877-9887.2002</ArticleId><ArticleId IdType="pmc">PMC136495</ArticleId><ArticleId IdType="pubmed">12208965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol. 2008;80:134&#x2013;146. doi: 10.1002/jmv.21051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21051</ArticleId><ArticleId IdType="pubmed">18041019</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, Rocha C, et al. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology. 2008;376:429&#x2013;435. doi: 10.1016/j.virol.2008.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.03.028</ArticleId><ArticleId IdType="pmc">PMC2546568</ArticleId><ArticleId IdType="pubmed">18452966</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Chow JS, Marchette NJ. Immunological enhancement of dengue virus replication. Nat New Biol. 1973;243:24&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">17319077</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 1977;265:739&#x2013;741. doi: 10.1038/265739a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/265739a0</ArticleId><ArticleId IdType="pubmed">404559</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier-Carvalho C, Cardoso CC, de Souza Kehdy F, Pacheco AG, Moraes MO. Host genetics and dengue fever. Infect Genet Evol. 2017;56:99&#x2013;110. doi: 10.1016/j.meegid.2017.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2017.11.009</ArticleId><ArticleId IdType="pubmed">29133029</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectr. 2014;2:AID-0022-2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">26104444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Phuklia W, Kalayanarooj S, Modhiran N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis. 2010;201:923&#x2013;935. doi: 10.1086/651018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/651018</ArticleId><ArticleId IdType="pubmed">20158392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou Z, Lim JY, Beltramello M, Quinn M, Chen H, Liu S, et al. Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Virology. 2011;410:240&#x2013;247. doi: 10.1016/j.virol.2010.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.11.007</ArticleId><ArticleId IdType="pubmed">21131015</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan MA, Killen HM. The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus. J Gen Virol. 1994;75:2387&#x2013;2392. doi: 10.1099/0022-1317-75-9-2387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-75-9-2387</ArticleId><ArticleId IdType="pubmed">8077937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, Perng GC, et al. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe. 2014;16:115&#x2013;127. doi: 10.1016/j.chom.2014.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.06.001</ArticleId><ArticleId IdType="pmc">PMC4116428</ArticleId><ArticleId IdType="pubmed">24981333</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha P, Geissmann F. Toward a functional characterization of blood monocytes. Immunol Cell Biol. 2011;89:2&#x2013;4. doi: 10.1038/icb.2010.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2010.130</ArticleId><ArticleId IdType="pubmed">21102535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Heitbrock L, Hofer TP. Toward a refined definition of monocyte subsets. Front Immunol. 2013;4:23. doi: 10.3389/fimmu.2013.00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00023</ArticleId><ArticleId IdType="pmc">PMC3562996</ArticleId><ArticleId IdType="pubmed">23382732</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyen HTL, Cerny D, Trung DT, Pang J, Velumani S, Toh YX, et al. Skin dendritic cell and T cell activation associated with dengue shock syndrome. Sci Rep. 2017;7:14224. doi: 10.1038/s41598-017-14640-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14640-1</ArticleId><ArticleId IdType="pmc">PMC5660158</ArticleId><ArticleId IdType="pubmed">29079750</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol. 1997;71:4226&#x2013;4232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191637</ArticleId><ArticleId IdType="pubmed">9151809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis. 1998;177:778&#x2013;782. doi: 10.1086/517807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/517807</ArticleId><ArticleId IdType="pubmed">9498463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg. 1993;48:324&#x2013;331. doi: 10.4269/ajtmh.1993.48.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1993.48.324</ArticleId><ArticleId IdType="pubmed">8470771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav M, Kamath KR, Iyngkaran N, Sinniah M. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? FEMS MicrobiolImmunol. 1991;89:45&#x2013;50. doi: 10.1111/j.1574-6968.1991.tb04969.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.1991.tb04969.x</ArticleId><ArticleId IdType="pubmed">1815710</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81:5518&#x2013;5526. doi: 10.1128/JVI.02575-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02575-06</ArticleId><ArticleId IdType="pmc">PMC1900309</ArticleId><ArticleId IdType="pubmed">17360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HR, Chuang YC, Lin YS, Liu HS, Liu CC, Perng GC, et al. Dengue virus nonstructural protein 1 induces vascular leakage through macrophage migration inhibitory factor and autophagy. PLoS Negl Trop Dis. 2016;10:e0004828. doi: 10.1371/journal.pntd.0004828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004828</ArticleId><ArticleId IdType="pmc">PMC4943727</ArticleId><ArticleId IdType="pubmed">27409803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang TH, Alonso S, Ng LF, Thein TL, Pang VJ, Leo YS, et al. Increased serum hyaluronic acid and heparan sulfate in dengue fever: association with plasma leakage and disease severity. Sci Rep. 2017;7:46191. doi: 10.1038/srep46191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46191</ArticleId><ArticleId IdType="pmc">PMC5385535</ArticleId><ArticleId IdType="pubmed">28393899</ArticleId></ArticleIdList></Reference><Reference><Citation>Trugilho MRO, Hottz ED, Brunoro GVF, Teixeira-Ferreira A, Carvalho PC, Salazar GA, et al. Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue. PLoS Pathog. 2017;13:e1006385. doi: 10.1371/journal.ppat.1006385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006385</ArticleId><ArticleId IdType="pmc">PMC5453622</ArticleId><ArticleId IdType="pubmed">28542641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol. 2014;193:1864&#x2013;1872. doi: 10.4049/jimmunol.1400091.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400091</ArticleId><ArticleId IdType="pmc">PMC4137323</ArticleId><ArticleId IdType="pubmed">25015827</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa VV, Ye W, Chen Q, Teixeira MM, Preiser P, Ooi EE, et al. Dengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules. MBio. 2017;8:e00741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5539423</ArticleId><ArticleId IdType="pubmed">28765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandini M, Petitinga-Paiva F, Marinho CF, Correa G, De Oliveira-Pinto LM, de Souza LJ, et al. Dengue virus induces NK cell activation through TRAIL expression during infection. Mediat Inflamm. 2017;2017:5649214. doi: 10.1155/2017/5649214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/5649214</ArticleId><ArticleId IdType="pmc">PMC5605866</ArticleId><ArticleId IdType="pubmed">29038620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan WH, Navarro-Sanchez E, Dumortier H, Decossas M, Vachon H, dos Santos FB, et al. Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis. 2008;2:e311. doi: 10.1371/journal.pntd.0000311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000311</ArticleId><ArticleId IdType="pmc">PMC2553280</ArticleId><ArticleId IdType="pubmed">18827881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerny D, Haniffa M, Shin A, Bigliardi P, Tan BK, Lee B, et al. Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog. 2014;10:e1004548. doi: 10.1371/journal.ppat.1004548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004548</ArticleId><ArticleId IdType="pmc">PMC4256468</ArticleId><ArticleId IdType="pubmed">25474532</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid MA, Harris E. Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog. 2014;10:e1004541. doi: 10.1371/journal.ppat.1004541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004541</ArticleId><ArticleId IdType="pmc">PMC4256458</ArticleId><ArticleId IdType="pubmed">25474197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamoutounour S, Guilliams M, Montanana Sanchis F, Liu H, Terhorst D, Malosse C, et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity. 2013;39:925&#x2013;938. doi: 10.1016/j.immuni.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.10.004</ArticleId><ArticleId IdType="pubmed">24184057</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint KS, Endy TP, Mongkolsirichaikul D, Manomuth C, Kalayanarooj S, Vaughn DW, et al. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. J Infect Dis. 2006;194:600&#x2013;607. doi: 10.1086/506451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/506451</ArticleId><ArticleId IdType="pubmed">16897658</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias J, Valero N, Mosquera J, Montiel M, Reyes E, Larreal Y, et al. Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. Virology. 2014;452-453:42&#x2013;51. doi: 10.1016/j.virol.2013.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.12.027</ArticleId><ArticleId IdType="pubmed">24606681</ArticleId></ArticleIdList></Reference><Reference><Citation>Klomporn P, Panyasrivanit M, Wikan N, Smith DR. Dengue infection of monocytic cells activates ER stress pathways, but apoptosis is induced through both extrinsic and intrinsic pathways. Virology. 2011;409:189&#x2013;197. doi: 10.1016/j.virol.2010.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.10.010</ArticleId><ArticleId IdType="pubmed">21047664</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy A, Valero N, Espina LM, Anez G, Arias J, Mosquera J. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg. 2010;104:16&#x2013;23. doi: 10.1016/j.trstmh.2009.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trstmh.2009.06.013</ArticleId><ArticleId IdType="pubmed">19733377</ArticleId></ArticleIdList></Reference><Reference><Citation>Espina LM, Valero NJ, Hernandez JM, Mosquera JA. Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg. 2003;68:48&#x2013;53. doi: 10.4269/ajtmh.2003.68.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2003.68.48</ArticleId><ArticleId IdType="pubmed">12556148</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrentes-Carvalho A, Azeredo EL, Reis SR, Miranda AS, Gandini M, Barbosa LS, et al. Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz. 2009;104:1091&#x2013;1099. doi: 10.1590/S0074-02762009000800005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0074-02762009000800005</ArticleId><ArticleId IdType="pubmed">20140369</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan TY, Chu JJ. Dengue virus-infected human monocytes trigger late activation of caspase-1, which mediates pro-inflammatory IL-1beta secretion and pyroptosis. J Gen Virol. 2013;94:2215&#x2013;2220. doi: 10.1099/vir.0.055277-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.055277-0</ArticleId><ArticleId IdType="pubmed">23884363</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189:1411&#x2013;1418. doi: 10.1086/383043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/383043</ArticleId><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg. 2009;80:416&#x2013;424. doi: 10.4269/ajtmh.2009.80.416.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2009.80.416</ArticleId><ArticleId IdType="pubmed">19270292</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackley S, Kou Z, Chen H, Quinn M, Rose RC, Schlesinger JJ, et al. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol. 2007;81:13325&#x2013;13334. doi: 10.1128/JVI.01568-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01568-07</ArticleId><ArticleId IdType="pmc">PMC2168870</ArticleId><ArticleId IdType="pubmed">17928355</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JL, de Wet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, et al. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 2008;4:e17. doi: 10.1371/journal.ppat.0040017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0040017</ArticleId><ArticleId IdType="pmc">PMC2233670</ArticleId><ArticleId IdType="pubmed">18266465</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer E, Flacher V, Papageorgiou V, Decossas M, Fauny JD, Kramer M, et al. Dermal CD14(+) dendritic cell and macrophage infection by dengue virus is stimulated by Interleukin-4. J Invest Dermatol. 2015;135:1743&#x2013;1751. doi: 10.1038/jid.2014.525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2014.525</ArticleId><ArticleId IdType="pubmed">25521455</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176:287&#x2013;292. doi: 10.1084/jem.176.1.287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.176.1.287</ArticleId><ArticleId IdType="pmc">PMC2119288</ArticleId><ArticleId IdType="pubmed">1613462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature. 2008;453:672&#x2013;676. doi: 10.1038/nature07013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07013</ArticleId><ArticleId IdType="pubmed">18496526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, Chen NJ, et al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood. 2013;121:95&#x2013;106. doi: 10.1182/blood-2012-05-430090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-05-430090</ArticleId><ArticleId IdType="pubmed">23152543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle JL, Beatty PR, Harris E. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis. 2007;195:1808&#x2013;1817. doi: 10.1086/518007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518007</ArticleId><ArticleId IdType="pubmed">17492597</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol. 2012;86:12138&#x2013;12147. doi: 10.1128/JVI.00375-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00375-12</ArticleId><ArticleId IdType="pmc">PMC3486461</ArticleId><ArticleId IdType="pubmed">22933295</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen YT, Chen HC, Lin YD, Shieh CC, Wu-Hsieh BA. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol. 2008;82:12312&#x2013;12324. doi: 10.1128/JVI.00968-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00968-08</ArticleId><ArticleId IdType="pmc">PMC2593312</ArticleId><ArticleId IdType="pubmed">18842737</ArticleId></ArticleIdList></Reference><Reference><Citation>Povoa TF, Oliveira ER, Basilio-de-Oliveira CA, Nuovo GJ, Chagas VL, Salomao NG, et al. Peripheral organs of dengue fatal cases present strong pro-inflammatory response with participation of IFN-gamma-, TNF-alpha- and RANTES-producing cells. PLoS One. 2016;11:e0168973. doi: 10.1371/journal.pone.0168973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168973</ArticleId><ArticleId IdType="pmc">PMC5179082</ArticleId><ArticleId IdType="pubmed">28006034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hober D, Delannoy AS, Benyoucef S, De GD, Wattre P. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol. 1996;40:569&#x2013;573. doi: 10.1111/j.1348-0421.1996.tb01110.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1996.tb01110.x</ArticleId><ArticleId IdType="pubmed">8887351</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MG, Hermann LL, Issekutz AC, Marshall JS, Rowter D, Al-Afif A, et al. Dengue virus infection of mast cells triggers endothelial cell activation. J Virol. 2011;85:1145&#x2013;1150. doi: 10.1128/JVI.01630-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01630-10</ArticleId><ArticleId IdType="pmc">PMC3019992</ArticleId><ArticleId IdType="pubmed">21068256</ArticleId></ArticleIdList></Reference><Reference><Citation>Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A, et al. Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol. 1999;73:5201&#x2013;5206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112571</ArticleId><ArticleId IdType="pubmed">10233989</ArticleId></ArticleIdList></Reference><Reference><Citation>Aye KS, Charngkaew K, Win N, Wai KZ, Moe K, Punyadee N, et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum Pathol. 2014;45:1221&#x2013;1233. doi: 10.1016/j.humpath.2014.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2014.01.022</ArticleId><ArticleId IdType="pubmed">24767772</ArticleId></ArticleIdList></Reference><Reference><Citation>Marianneau P, Flamand M, Deubel V, Despres P. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited. Clin Diagn Virol. 1998;10:113&#x2013;119. doi: 10.1016/S0928-0197(98)00031-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0928-0197(98)00031-2</ArticleId><ArticleId IdType="pubmed">9741636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JC, Lin SC, Chen WY, Yen YT, Lai CW, Tao MH, et al. Dengue viral protease interaction with NF-kappaB inhibitor alpha/beta results in endothelial cell apoptosis and hemorrhage development. J Immunol. 2014;193:1258&#x2013;1267. doi: 10.4049/jimmunol.1302675.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302675</ArticleId><ArticleId IdType="pubmed">24973451</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol. 2004;4:787&#x2013;799. doi: 10.1038/nri1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1460</ArticleId><ArticleId IdType="pubmed">15459670</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol. 2007;19:31&#x2013;38. doi: 10.1016/j.coi.2006.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2006.11.006</ArticleId><ArticleId IdType="pubmed">17126541</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology. 2008;213:251&#x2013;260. doi: 10.1016/j.imbio.2007.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2007.10.017</ArticleId><ArticleId IdType="pubmed">18406371</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli SJ, Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci. 2008;49:7&#x2013;19. doi: 10.1016/j.jdermsci.2007.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdermsci.2007.09.009</ArticleId><ArticleId IdType="pmc">PMC2788430</ArticleId><ArticleId IdType="pubmed">18024086</ArticleId></ArticleIdList></Reference><Reference><Citation>Selye H. Mast cells and necrosis. Science. 1966;152:1371&#x2013;1372. doi: 10.1126/science.152.3727.1371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.152.3727.1371</ArticleId><ArticleId IdType="pubmed">4287063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM. Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol. 1981;61:465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">6177155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperr WR, Bankl HC, Mundigler G, Klappacher G, Grossschmidt K, Agis H, et al. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood. 1994;84:3876&#x2013;3884.</Citation><ArticleIdList><ArticleId IdType="pubmed">7524750</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo CB, Kagey-Sobotka A, Lichtenstein LM, Bochner BS. Immunophenotyping and functional analysis of purified human uterine mast cells. Blood. 1992;79:708&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">1370642</ArticleId></ArticleIdList></Reference><Reference><Citation>Okayama Y, Hagaman DD, Woolhiser M, Metcalfe DD. Further characterization of FcgammaRII and FcgammaRIII expression by cultured human mast cells. Int Arch Allergy Immunol. 2001;124:155&#x2013;157. doi: 10.1159/000053696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000053696</ArticleId><ArticleId IdType="pubmed">11306954</ArticleId></ArticleIdList></Reference><Reference><Citation>Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-affinity IgG receptor, fc gamma RI, on human mast cells: up-regulation by IFN-gamma. J Immunol. 2000;164:4332&#x2013;4339. doi: 10.4049/jimmunol.164.8.4332.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.8.4332</ArticleId><ArticleId IdType="pubmed">10754333</ArticleId></ArticleIdList></Reference><Reference><Citation>Okayama Y, Hagaman DD. Metcalfe DD. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of fc gamma RI or fc epsilon RI. J Immunol. 2001;166:4705&#x2013;4712. doi: 10.4049/jimmunol.166.7.4705.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.7.4705</ArticleId><ArticleId IdType="pubmed">11254731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedi B, Lewrick H, Butterfield JH, Kapp A. Human HMC-1 mast cells exclusively express the fc gamma RII subtype of IgG receptor. Arch Dermatol Res. 1996;289:21&#x2013;27. doi: 10.1007/s004030050147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004030050147</ArticleId><ArticleId IdType="pubmed">9017131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med. 2000;6:816&#x2013;820. doi: 10.1038/77553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/77553</ArticleId><ArticleId IdType="pubmed">10888933</ArticleId></ArticleIdList></Reference><Reference><Citation>St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A. 2011;108:9190&#x2013;9195. doi: 10.1073/pnas.1105079108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1105079108</ArticleId><ArticleId IdType="pmc">PMC3107258</ArticleId><ArticleId IdType="pubmed">21576486</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchinda M, Dhorranintra B, Tuchinda P. Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health. 1977;8:80&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">887998</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan DT, Ha NT, Thuc LT, Diet NH, Phu LV, Ninh LY, et al. Some changes in immunity and blood in relation to clinical states of dengue hemorrhagic fever patients in Vietnam. Haematologia (Budap) 1991;24:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">1813358</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta T, Murao LA, Lan NT, Huy NT, Huong VT, Thuy TT, et al. Association of mast cell-derived VEGF and proteases in dengue shock syndrome. PLoS Negl Trop Dis. 2012;6:e1505. doi: 10.1371/journal.pntd.0001505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001505</ArticleId><ArticleId IdType="pmc">PMC3283553</ArticleId><ArticleId IdType="pubmed">22363824</ArticleId></ArticleIdList></Reference><Reference><Citation>St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. elife. 2013;2:e00481. doi: 10.7554/eLife.00481.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00481</ArticleId><ArticleId IdType="pmc">PMC3639510</ArticleId><ArticleId IdType="pubmed">23638300</ArticleId></ArticleIdList></Reference><Reference><Citation>King CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell chemokine production. J Virol. 2002;76:8408&#x2013;8419. doi: 10.1128/JVI.76.16.8408-8419.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.16.8408-8419.2002</ArticleId><ArticleId IdType="pmc">PMC155122</ArticleId><ArticleId IdType="pubmed">12134044</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MG, McAlpine SM, Huang YY, Haidl ID, Al-Afif A, Marshall JS, et al. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS One. 2012;7:e34055. doi: 10.1371/journal.pone.0034055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034055</ArticleId><ArticleId IdType="pmc">PMC3316603</ArticleId><ArticleId IdType="pubmed">22479521</ArticleId></ArticleIdList></Reference><Reference><Citation>King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol. 2000;74:7146&#x2013;7150. doi: 10.1128/JVI.74.15.7146-7150.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.15.7146-7150.2000</ArticleId><ArticleId IdType="pmc">PMC112233</ArticleId><ArticleId IdType="pubmed">10888655</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MG, King CA, Sherren C, Marshall JS, Anderson R. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol. 2006;80:1242&#x2013;1250. doi: 10.1189/jlb.0805441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0805441</ArticleId><ArticleId IdType="pubmed">16940332</ArticleId></ArticleIdList></Reference><Reference><Citation>Orinska Z, Bulanova E, Budagian V, Metz M, Maurer M, Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood. 2005;106:978&#x2013;987. doi: 10.1182/blood-2004-07-2656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-07-2656</ArticleId><ArticleId IdType="pubmed">15840693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor 3. J Allergy Clin Immunol. 2004;114:174&#x2013;182. doi: 10.1016/j.jaci.2004.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2004.03.049</ArticleId><ArticleId IdType="pubmed">15241362</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, Cabrera MV, et al. IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol. 2004;73:230&#x2013;234. doi: 10.1002/jmv.20080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20080</ArticleId><ArticleId IdType="pubmed">15122797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Lee YH, Thein TL, Fang J, Pang J, Ooi EE, et al. Serum metabolomics reveals serotonin as a predictor of severe dengue in the early phase of dengue fever. PLoS Negl Trop Dis. 2016;10:e0004607. doi: 10.1371/journal.pntd.0004607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004607</ArticleId><ArticleId IdType="pmc">PMC4824427</ArticleId><ArticleId IdType="pubmed">27055163</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Weg CA, Pannuti CS, de Araujo ES, van den Ham HJ, Andeweg AC, Boas LS, et al. Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease. PLoS Negl Trop Dis. 2013;7:e2236. doi: 10.1371/journal.pntd.0002236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002236</ArticleId><ArticleId IdType="pmc">PMC3662706</ArticleId><ArticleId IdType="pubmed">23717702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis. 2008;8:86. doi: 10.1186/1471-2334-8-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-8-86</ArticleId><ArticleId IdType="pmc">PMC2474613</ArticleId><ArticleId IdType="pubmed">18578883</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagoner J, Austin M, Green J, Imaizumi T, Casola A, Brasier A, et al. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol. 2007;81:309&#x2013;318. doi: 10.1128/JVI.01411-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01411-06</ArticleId><ArticleId IdType="pmc">PMC1797246</ArticleId><ArticleId IdType="pubmed">17035306</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H, Imaizumi T, Lee SJ, Tanji K, Sakaki H, Matsumiya T, et al. Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci Res. 2007;58:199&#x2013;206. doi: 10.1016/j.neures.2007.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2007.02.017</ArticleId><ArticleId IdType="pubmed">17395328</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology. 2001;289:297&#x2013;311. doi: 10.1006/viro.2001.1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1114</ArticleId><ArticleId IdType="pubmed">11689052</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol. 2004;173:531&#x2013;541. doi: 10.4049/jimmunol.173.1.531.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.1.531</ArticleId><ArticleId IdType="pubmed">15210814</ArticleId></ArticleIdList></Reference><Reference><Citation>McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol. 2003;170:1625&#x2013;1629. doi: 10.4049/jimmunol.170.4.1625.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.4.1625</ArticleId><ArticleId IdType="pubmed">12574323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka M, Metcalfe DD. TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol. 2006;43:1579&#x2013;1586. doi: 10.1016/j.molimm.2005.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2005.09.019</ArticleId><ArticleId IdType="pubmed">16280166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonini S, Micera A, Iovieno A, Lambiase A, Bonini S. Expression of toll-like receptors in healthy and allergic conjunctiva. Ophthalmology. 2005;112:1528&#x2013;1534. doi: 10.1016/j.ophtha.2005.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2005.04.009</ArticleId><ArticleId IdType="pubmed">16023216</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke SM, Issekutz TB, Mohan K, Lee PW, Shmulevitz M, Marshall JS. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood. 2008;111:5467&#x2013;5476. doi: 10.1182/blood-2007-10-118547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-10-118547</ArticleId><ArticleId IdType="pubmed">18424663</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL, Fredericksen BL. How flaviviruses activate and suppress the interferon response. Viruses. 2010;2:676&#x2013;691. doi: 10.3390/v2020676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v2020676</ArticleId><ArticleId IdType="pmc">PMC3185611</ArticleId><ArticleId IdType="pubmed">21994652</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, Liu DX. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis. 2011;5:e926. doi: 10.1371/journal.pntd.0000926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000926</ArticleId><ArticleId IdType="pmc">PMC3014945</ArticleId><ArticleId IdType="pubmed">21245912</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin CF, Zhao H, Liu ZY, Jiang T, Deng YQ, Yu XD, et al. Retinoic acid inducible gene-I and melanoma differentiation-associated gene 5 are induced but not essential for dengue virus induced type I interferon response. Mol Biol Rep. 2011;38:3867&#x2013;3873. doi: 10.1007/s11033-010-0502-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-010-0502-7</ArticleId><ArticleId IdType="pubmed">21113677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu YT, Wan SW, Anderson R, Lin YS. Mast cell-macrophage dynamics in modulation of dengue virus infection in skin. Immunology. 2015;146:163&#x2013;172. doi: 10.1111/imm.12492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12492</ArticleId><ArticleId IdType="pmc">PMC4552511</ArticleId><ArticleId IdType="pubmed">26059780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissera H, Rathore APS, Leong WY, Pike BL, Warkentien TE, Farouk FS, et al. Chymase level is a predictive biomarker of dengue hemorrhagic fever in pediatric and adult patients. J Infect Dis. 2017;216:1112&#x2013;1121. doi: 10.1093/infdis/jix447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix447</ArticleId><ArticleId IdType="pmc">PMC5853622</ArticleId><ArticleId IdType="pubmed">28968807</ArticleId></ArticleIdList></Reference><Reference><Citation>Syenina A, Jagaraj CJ, Aman SA, Sridharan A, St John AL. Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcgamma receptors. elife. 2015;4:e05291. doi: 10.7554/eLife.05291.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.05291</ArticleId><ArticleId IdType="pmc">PMC4362203</ArticleId><ArticleId IdType="pubmed">25783751</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J, Rathore APS, Mantri CK, Aman SAB, Nishida A, St John AL. Transcriptional profiling confirms the therapeutic effects of mast cell stabilization in a dengue disease model. J Virol. 2017;91:e00617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5571258</ArticleId><ArticleId IdType="pubmed">28659489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu YT, Wan SW, Chang YC, Lee CK, Wu-Hsieh BA, Anderson R, et al. Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation. Lab Investig. 2017;97:602&#x2013;614. doi: 10.1038/labinvest.2017.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2017.10</ArticleId><ArticleId IdType="pubmed">28240747</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MG, Huang YY, Marshall JS, King CA, Hoskin DW, Anderson R. Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. J Leukoc Biol. 2009;85:71&#x2013;80. doi: 10.1189/jlb.0308167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0308167</ArticleId><ArticleId IdType="pubmed">18809735</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>